TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Wellnex Life Ltd ( (AU:WNX) ) just unveiled an update.
Wellnex Life Limited reported a 40.5% increase in revenue for FY25, reaching A$23.6 million, driven by the full-year contribution from its Pain Away brand. Despite a net loss of A$15.6 million, the company improved its gross margin in the second half of the year through a refined trade investment strategy. The dual listing on the AIM Market and associated capital raising helped settle significant financial obligations, positioning Wellnex for future growth. The company aims to enhance revenue and margins in FY26 by leveraging its leading Pain Away brand and expanding contract manufacturing partnerships.
More about Wellnex Life Ltd
Wellnex Life Limited operates in the health and pharmaceutical industry, focusing on the development, marketing, and selling of premium brands and products. The company also licenses its innovative products to domestic and global pharmaceutical companies.
For a thorough assessment of WNX stock, go to TipRanks’ Stock Analysis page.